These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 31476616
1. Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents. Zhang YL, Yang R, Xia LY, Man RJ, Chu YC, Jiang AQ, Wang ZC, Zhu HL. Bioorg Chem; 2019 Nov; 92():103219. PubMed ID: 31476616 [Abstract] [Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. Wang YT, Shi TQ, Zhu HL, Liu CH. Bioorg Med Chem; 2019 Feb 01; 27(3):502-515. PubMed ID: 30606674 [Abstract] [Full Text] [Related]
3. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL. Eur J Med Chem; 2015 Jun 24; 99():125-37. PubMed ID: 26070164 [Abstract] [Full Text] [Related]
4. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors. Wang YT, Cai XC, Shi TQ, Zhang YL, Wang ZC, Liu CH, Zhu HL. Chem Biol Drug Des; 2017 Jul 24; 90(1):112-118. PubMed ID: 28032450 [Abstract] [Full Text] [Related]
5. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS, Tabeshpour J, Mirzaei S, Golmakaniyoon S, Tayarani-Najaran Z, Ghasemi A, Ghodsi R. Arch Pharm (Weinheim); 2019 Jun 24; 352(6):e1800307. PubMed ID: 31012156 [Abstract] [Full Text] [Related]
6. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S, An B, Li Y, Luo X, Li X, Jia X. Bioorg Med Chem Lett; 2018 Jun 01; 28(10):1769-1775. PubMed ID: 29673981 [Abstract] [Full Text] [Related]
7. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Rahimzadeh Oskuei S, Mirzaei S, Reza Jafari-Nik M, Hadizadeh F, Eisvand F, Mosaffa F, Ghodsi R. Bioorg Chem; 2021 Jul 01; 112():104904. PubMed ID: 33933802 [Abstract] [Full Text] [Related]
8. Design, synthesis, and biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors. Xia LY, Yang R, Zhang YL, Chu YC, Qi YL, Man RJ, Wang ZC, Wang BZ, Zhu HL. Chem Biol Drug Des; 2019 Sep 01; 94(5):1894-1904. PubMed ID: 31106514 [Abstract] [Full Text] [Related]
9. Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity. Mourad AAE, Mourad MAE, Jones PG. Drug Des Devel Ther; 2020 Sep 01; 14():3111-3130. PubMed ID: 32848361 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors. Shobeiri N, Rashedi M, Mosaffa F, Zarghi A, Ghandadi M, Ghasemi A, Ghodsi R. Eur J Med Chem; 2016 May 23; 114():14-23. PubMed ID: 26974371 [Abstract] [Full Text] [Related]
11. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. Qin YJ, Li YJ, Jiang AQ, Yang MR, Zhu QZ, Dong H, Zhu HL. Eur J Med Chem; 2015 Apr 13; 94():447-57. PubMed ID: 25828827 [Abstract] [Full Text] [Related]
12. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors. Wang G, Liu W, Gong Z, Huang Y, Li Y, Peng Z. Bioorg Chem; 2020 Jan 13; 95():103565. PubMed ID: 31927336 [Abstract] [Full Text] [Related]
13. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization. Jadala C, Sathish M, Anchi P, Tokala R, Lakshmi UJ, Reddy VG, Shankaraiah N, Godugu C, Kamal A. ChemMedChem; 2019 Dec 17; 14(24):2052-2060. PubMed ID: 31674147 [Abstract] [Full Text] [Related]
14. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities. Abdel-Aziz M, Metwally KA, Gamal-Eldeen AM, Aly OM. Anticancer Agents Med Chem; 2015 Dec 17; 16(2):269-77. PubMed ID: 26343141 [Abstract] [Full Text] [Related]
15. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors. Yang F, He CP, Diao PC, Hong KH, Rao JJ, Zhao PL. Bioorg Med Chem Lett; 2019 Jan 01; 29(1):22-27. PubMed ID: 30448234 [Abstract] [Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition. Li SS, Chen JJ, Zhang MM, Wang WX, Zhang WY, Ma C. Eur J Med Chem; 2024 May 05; 271():116425. PubMed ID: 38636129 [Abstract] [Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T, Mikstacka R, Kurczab R, Dutkiewicz Z, Kucińska M, Murias M, Zielińska-Przyjemska M, Cichocki M, Teubert A, Kaczmarek M, Hogendorf A, Sobiak S. Eur J Med Chem; 2018 Jan 20; 144():797-816. PubMed ID: 29291446 [Abstract] [Full Text] [Related]
18. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R, Kimatrai Salvador M, Schiaffino Ortega S, Baraldi PG, Oliva P, Baraldi S, Lopez-Cara LC, Brancale A, Ferla S, Hamel E, Balzarini J, Liekens S, Mattiuzzo E, Basso G, Viola G. Eur J Med Chem; 2018 Jan 01; 143():683-698. PubMed ID: 29220790 [Abstract] [Full Text] [Related]
19. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. Hagras M, El Deeb MA, Elzahabi HSA, Elkaeed EB, Mehany ABM, Eissa IH. J Enzyme Inhib Med Chem; 2021 Dec 01; 36(1):640-658. PubMed ID: 33588683 [Abstract] [Full Text] [Related]
20. Development of Benzimidazole-Substituted Spirocyclopropyl Oxindole Derivatives as Cytotoxic Agents: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies. Sakla AP, Bazaz MR, Mahale A, Sharma P, Valapil DG, Kulkarni OP, Dandekar MP, Shankaraiah N. ChemMedChem; 2024 Jun 17; 19(12):e202400052. PubMed ID: 38517377 [Abstract] [Full Text] [Related] Page: [Next] [New Search]